Details for New Drug Application (NDA): 062816
✉ Email this page to a colleague
The generic ingredient in AMPICILLIN SODIUM is ampicillin sodium. There are seventy drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ampicillin sodium profile page.
Summary for 062816
Tradename: | AMPICILLIN SODIUM |
Applicant: | Watson Labs Inc |
Ingredient: | ampicillin sodium |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062816
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 125MG BASE/VIAL | ||||
Approval Date: | Oct 24, 1988 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 250MG BASE/VIAL | ||||
Approval Date: | Oct 24, 1988 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | Oct 24, 1988 | TE: | RLD: | No |
Complete Access Available with Subscription